Results 211 to 220 of about 11,348 (239)

Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis. [PDF]

Respir Med Case Rep
Kawasaki Y, Nishiki K, Ishizaki T.
europepmc   +1 more source

Th2-skewed peripheral T-helper cells drive B-cells in allergic bronchopulmonary aspergillosis. [PDF]

Eur Respir J
Luo RG, Wu YF, Lu HW, Weng D, Xu JY, Wang LL, Zhang LS, Zhao CQ, Li JX, Yu Y, Jia XM, Xu JF.   +11 more
europepmc   +1 more source

Efficacy of omalizumab in adult patients with allergic bronchopulmonary aspergillosis: a multicentre study in China. [PDF]

Clin Exp Med
Chen P, Yu Y, He L, Zhang C, Li Y, Wu D, Chen Y, Wang R, Xu G, Cao C.   +9 more
europepmc   +1 more source

Allergic bronchopulmonary aspergillosis treated successfully with omalizumab

Revista Portuguesa de Pneumologia (English Edition), 2017
R. Aguiar, N.P. Fernandes, A. Lopes, C. Lopes   +3 more
doaj  

Allergic bronchopulmonary aspergillosis

, 2011
openaire   +1 more source

Allergic Bronchopulmonary Aspergillosis [PDF]

CHEST Journal, 1985
Allergic bronchopulmonary aspergillosis (ABPA) occurs as a complication of asthma. It presents as an infiltrative pulmonary disorder with respiratory and systemic symptoms, eosinophilia, elevated total serum IgE, and skin sensitizing, as well as precipitating antibodies to Aspergillus fumigatus. Sputum cultures are not always positive for the organism.
openaire   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Allergic bronchopulmonary aspergillosis

Journal of Allergy and Clinical Immunology, 1984
Allergic bronchopulmonary aspergillosis (ABPA) complicates asthma and cystic fibrosis. The survival factors in Aspergillus fumigatus that support saprophytic growth in bronchial mucus are not understood. Prednisone remains the most definitive treatment but need not be administered indefinitely.
Roy Patterson, Richard A. Mintzer, Anthony J. Ricketti, Paul A. Greenberger   +3 more
openaire   +7 more sources

Allergic Bronchopulmonary Aspergillosis

Clinics in Chest Medicine, 2022
Allergic bronchopulmonary aspergillosis (ABPA) is a complex allergic disorder caused by immune reactions against Aspergillus fumigatus. ABPA most commonly complicates the course of patients with poorly controlled asthma. Patients commonly present with uncontrolled asthma, fleeting pulmonary opacities, and bronchiectasis.
Ritesh, Agarwal, Valliappan, Muthu, Inderpaul S, Sehgal, Sahajal, Dhooria, Kuruswamy T, Prasad, Ashutosh N, Aggarwal   +5 more
openaire   +2 more sources

Allergic Bronchopulmonary Aspergillosis

Proceedings of the American Thoracic Society, 2010
Allergic bronchopulmonary aspergillosis (ABPA) is a complex clinical entity that results from an allergic immune response to Aspergillus fumigatus, most often occurring in a patient with asthma or cystic fibrosis. Sensitization to aspergillus in the allergic host leads to activation of T helper 2 lymphocytes, which play a key role in recruiting ...
Karen, Patterson, Mary E, Strek
openaire   +2 more sources